Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Warning Over Potentially Toxic Chinese Herbal Medicine

Published: Thursday, April 18, 2013
Last Updated: Thursday, April 18, 2013
Bookmark and Share
MHRA warn people not to use Zheng Tian Wan to treat migraines.

The MHRA is warning people not to use a particular Chinese herbal medicine, used to treat migraines, as it contains a potentially toxic herbal ingredient.

The product, Zheng Tian Wan consists of herbal pills which contain aconite, a poisonous plant toxic to the heart and the nervous system and linked to serious health complications including deaths.

This product has recently come to the attention of the MHRA as a result of being supplied to a patient by an herbal practitioner.

Aconite (also known as monkshood) is on a UK list of restricted herbal ingredients. Aconite should not be used in unlicensed products for oral use and Herbal practitioners in the UK should only use aconite in preparations for external use only on unbroken skin. It can be prescribed in oral medicines by a qualified medical doctor under supervision as a prescription-only medicine.

The product is an unlicensed herbal medicine which means it has not been assessed for safety and quality by the MHRA.

The MHRA has previously received three reports of suspected side effects to aconite, one where a patient suffered kidney problems a second person was hospitalized after suffering dizziness and ‘pins and needles’ (paraesthesia) and the third experienced palpitations, aches and pains with shortness of breath but recovered after stopping taking the product.

Andrea Farmer, Herbal Policy Manager at the MHRA said: “Herbal medicines can have a very significant effect on the body. In certain circumstances, such as with aconite taken orally, they can be extremely dangerous.

Products intended for oral use containing aconite are not permitted in the UK without appropriate authorization.

If users have taken Zheng Tian Wan or any other aconite -containing product, speak to their GP or healthcare professional as soon as possible.

“Natural does not mean safe. To help you choose an herbal medicine that is suitable for you, look for a product that has a Traditional Herbal Registration (THR) or product license number on the packaging. These products have met the acceptable quality and safety standards.

“And if you think you have suffered a side effect to an herbal medicine, please tell us about it through our Yellow Card Scheme at www.yellowcard.mhra.gov.uk.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

UK Moves Towards Safe and Effective Electronic Cigarettes and Other NCPs
All nicotine-containing products, such as electronic cigarettes, are to be regulated as medicines in a move to make these products safer and more effective to reduce the harms of smoking.
Friday, July 12, 2013
MHRA Appoints New Chief Executive
The Medicines and Healthcare Products Regulatory Agency (MHRA) announced the appointment of Dr Ian Hudson as its Chief Executive.
Friday, July 05, 2013
Man Jailed in Pre-Clinical Trial Data Scam Case
The man was sentenced to three months in prison for altering pre-clinical trial data designed to support applications to perform clinical trials.
Friday, April 19, 2013
MHRA Prioritises Science and Research Support as Part of New Corporate Plan
MHRA announced its aim to be a leading regulator on the world stage in supporting science and research as part of its new five-year corporate plan.
Monday, April 15, 2013
Side Effects to be Discovered more Quickly, Leading to Safer Prescribing
BMJ Learning has teamed up with the MHRA to launch a new, interactive and multimedia learning module on pharmacovigilance.
Monday, April 15, 2013
The Medicines Act Hits 40
The 25th October 2008 will mark the 40th birthday of the Medicines Act. For the past 40 years, the Act has served as the corner-stone of domestic medicines regulation, safe guarding public health.
Friday, October 24, 2008
New Web Resource About Medicines
From today, people can access a new authoritative source of information on the Internet about medicines.
Friday, September 26, 2008
British Pharmacopoeia Launches New Website
The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched the new British Pharmacopoeia (BP) website www.pharmacopoeia.gov.uk.
Tuesday, September 09, 2008
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Bioreactors Ready for the Big Time
Bioreactors are passive filtration systems that can reduce nitrate losses from farm fields.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!